Immunofluoresence staining results showed that a majority of both SU2 and U87s cells strongly expressed glioma stem cell marker CD133 in CD133+ group and did not express CD133 marker in CD133- group, which mediate self-renewal and proliferation of stem cells (Figure 3). The gene discussed is PROM1; the disease is central nervous system cancer.